Citadel Advisors »

Dianthus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $43M 1.1M 39.35
2025-06-30 $12M 665k 18.63
2025-03-31 $8.7M 480k 18.14
2024-12-31 $9.2M 423k 21.80
2024-09-30 $1.6M 60k 27.38
2024-03-31 $745k 25k 30.00
2023-09-30 $1.4M 106k 13.67